Cargando…
Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer’s Disease Clinical Trials
Alzheimer’s disease (AD) patients have varying responses to AD drugs and there may be no single treatment for all AD patients. Trial after trial shows that identifying non-responsive and responsive subgroups and their corresponding moderators will provide better insights into subject selection and i...
Autores principales: | Wang, Dulin, Ling, Yaobin, Harris, Kristofer, Schulz, Paul E., Jiang, Xiaoqian, Kim, Yejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635230/ https://www.ncbi.nlm.nih.gov/pubmed/37961216 http://dx.doi.org/10.1101/2023.10.27.23297685 |
Ejemplares similares
-
Do vaccinations influence the development of Alzheimer disease?
por: Bukhbinder, Avram S., et al.
Publicado: (2023) -
The Impact of Routine Vaccinations on Alzheimer’s Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching
por: Harris, Kristofer, et al.
Publicado: (2023) -
Defining Responders vs Non-Responders After Total Ankle Arthroplasty
por: Steele, John R., et al.
Publicado: (2019) -
Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease Reversal
por: Hubbard, Catherine S., et al.
Publicado: (2016) -
The Danish Hip Arthroscopy Registry: Registration Completeness and Patient Characteristics Between Responders and Non-Responders
por: Poulsen, Erik, et al.
Publicado: (2020)